The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poussin, M. A.
Right arrow Articles by Christadoss, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poussin, M. A.
Right arrow Articles by Christadoss, P.
The Journal of Immunology, 2003, 170: 4389-4396.
Copyright © 2003 by The American Association of Immunologists

B7-1 Costimulatory Molecule Is Critical for the Development of Experimental Autoimmune Myasthenia Gravis1

Mathilde A. Poussin2, Erdem Tüzün, Elzbieta Goluszko, Benjamin G. Scott, Huan Yang, Juan U. Franco and Premkumar Christadoss3

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555

Following immunization with acetylcholine receptor (AChR), MHC class II-restricted, AChR-specific CD4 cell activation is critical for the development of experimental autoimmune myasthenia gravis (EAMG) in C57BL/6 mice. To study the contributions of B7-1 and B7-2 costimulatory molecules in EAMG, B7-1, B7-2, and B7-1/B7-2 gene knockout (KO) mice were immunized with Torpedo AChR in CFA. Compared with wild-type C57BL6 mice, B7-1 and B7-1/2 KO mice were resistant to EAMG development. B7-1 KO mice had reduced anti-AChR Ab compared with C57BL/6 mice. However, neither B7-1 nor B7-2 gene disruption impaired AChR-induced or dominant {alpha}146–162 peptide-induced in vitro lymphoproliferative responses. Blocking of the B7-1 or B7-2 molecule by specific mAbs in vivo led to a reduction in the AChR-specific lymphocyte response, and the reduction was more pronounced in mice treated with anti-B7-2 Ab. The findings implicate B7-1 molecules as having a critical role in the induction of EAMG, and the resistance of B7-1 KO mice is associated with suppressed humoral, rather than suppressed AChR-specific, T cell responses. The data also point to B7-2 molecules as being the dominant costimulatory molecules required for AChR-induced lymphocyte proliferation.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Kawano, S. Shimoda, T. Kamihira, F. Ishikawa, H. Niiro, Y. Soejima, A. Taketomi, Y. Maehara, M. Nakamura, A. Komori, et al.
Peripheral Tolerance and the Qualitative Characteristics of Autoreactive T Cell Clones in Primary Biliary Cirrhosis
J. Immunol., September 1, 2007; 179(5): 3315 - 3324.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Saudemont, N. Jouy, D. Hetuin, and B. Quesnel
NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells
Blood, March 15, 2005; 105(6): 2428 - 2435.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hussain and T. L. Delovitch
Dysregulated B7-1 and B7-2 Expression on Nonobese Diabetic Mouse B Cells Is Associated with Increased T Cell Costimulation and the Development of Insulitis
J. Immunol., January 15, 2005; 174(2): 680 - 687.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Saudemont and B. Quesnel
In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis
Blood, October 1, 2004; 104(7): 2124 - 2133.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Yadav, V. Judkowski, M. Flodstrom-Tullberg, L. Sterling, W. L. Redmond, L. Sherman, and N. Sarvetnick
B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets
J. Immunol., September 15, 2004; 173(6): 3631 - 3639.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Tuzun, B. G. Scott, H. Yang, B. Wu, E. Goluszko, M. Guigneaux, S. Higgs, and P. Christadoss
Circulating Immune Complexes Augment Severity of Antibody-Mediated Myasthenia Gravis in Hypogammaglobulinemic RIIIS/J Mice
J. Immunol., May 1, 2004; 172(9): 5743 - 5752.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.